MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)

Meeting: 2019 International Congress

Abstract Number: 1751

Keywords: Apoptosis, Bradykinesia, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Physiology and Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Objective: To evaluate whether type 2 diabetes at baseline is a risk factor for Parkinson’s disease.

Background: Parkinson’s disease is a chronic disorder in which part of the brain is damaged. This occurs over a long-term period and mainly affects how muscle movement is coordinated.

Method: We prospectively followed 51,552 Finnish men and women 25–74 years of age without a history of Parkinson’s disease at baseline. History of diabetes and other study parameters were determined at baseline using standardized measurements. Ascertainment of the Parkinson’s disease status was based on the nationwide Social Insurance Institution’s drug register data. Hazard ratios of incident Parkinson’s disease associated with the history of type 2 diabetes were estimated.

Results: During a mean follow-up period of 11.0 years, 318 men and 304 women developed incident Parkinson’s disease. Age- and study year–adjusted hazard ratios of incident Parkinson’s disease among subjects with type 2 diabetes, compared with those without it, were 1.780 (95% CI 1.03–3.15) in men, 1.96 (1.05–3.53) in women, and 1.81 (1.23–2.80) in men and women combined (adjusted also for sex). Further adjustment for BMI, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol drinking, and coffee and tea consumption affected the results only slightly. The multivariate adjusted association between type 2 diabetes and the risk of Parkinson’s disease was also confirmed in stratified subgroup analysis.

Conclusion: Our data show that type 2 diabetes is associated with high risk of Parkinson’s disease. Surveillance bias might account for higher rates in diabetes. The mechanism  association between diabetes and Parkinson’s disease is not known.

To cite this abstract in AMA style:

F. Akhmedova, M. Tukhtamishev. Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2. [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/risk-of-developing-the-parkinsons-disease-against-the-background-of-diabetes-mellitus-type-2/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/risk-of-developing-the-parkinsons-disease-against-the-background-of-diabetes-mellitus-type-2/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley